COVID-19 vaccine triggered autoimmune hepatitis: case report
10.1136/ejhpharm-2022-003485
October 7, 2022
Most Read Articles
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series
10.1136/ejhpharm-2022-003544
December 19, 2022
Antifungal drug resistance: an update
10.1136/ejhpharm-2020-002604
February 21, 2022
Editor's choice
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards
10.1136/ejhpharm-2021-002729
May 14, 2021
Editor's choice
Hospital pharmaceutical expenditure: a need to focus on an ‘obscure’ and growing component of pharmaceutical spending
10.1136/ejhpharm-2022-003568
November 8, 2022
Is peer review running out of steam?
10.1136/ejhpharm-2022-003564
October 25, 2022
Use of chronic medications and risk of severe death due to COVID-19 in hospitalised patients
10.1136/ejhpharm-2021-003186
October 27, 2022
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results
10.1136/ejhpharm-2021-003194
April 20, 2022
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
10.1136/ejhpharm-2020-002669
February 24, 2021
Drug-related problems in hospitalised Parkinson’s disease patients in China
10.1136/ejhpharm-2020-002356
October 30, 2020